Forums
All
GSK
GSK
 
Notifications
Clear all

GSK - GSK - Share Chat

Price: Market Cap.: (£m)

GSK plc is a UK-headquartered global biopharmaceutical company, a prominent constituent of the FTSE 100. Following the demerger of its Consumer Healthcare division (now Haleon) in 2022, GSK has intensified its focus on its core Prescription Medicines and Vaccines businesses.

The company’s strategy centres on scientific innovation, particularly in four key therapeutic areas: Infectious Diseases (including a robust HIV franchise), Oncology, Immunology, and Respiratory. GSK is a major player in vaccine development, with key products like Shingrix and the recent RSV vaccine, Arexvy. It is committed to leveraging its R&D capabilities to develop new medicines and vaccines addressing significant unmet medical needs, aiming to deliver long-term sustainable growth and value for shareholders.

 
Posts: 1675
 Mr Multibagger
Topic starter
Oct 03, 2025 2:45 pm
(@mrmultibagger)
Member
Joined: 3 years ago

Chat about GSK


1 Reply
Posts: 1675
 Mr Multibagger
Topic starter
Oct 03, 2025 2:46 pm
(@mrmultibagger)
Member
Joined: 3 years ago

GSK's Q1 results certainly impressed, boosting full-year guidance! With strong Shingrix and Arexvy sales, the company seems to be firing on all cylinders. What's everyone's take on the current valuation? Are the pipeline prospects strong enough for long-term growth, or is it already priced in? Interested to hear your thoughts on its future.


Reply
Forum Jump:

Scroll to Top